Ms. Powell-Elliott is vice president and chief innovation and commercialization officer at Hackensack Meridian Health, where she advances internal innovation culture and external commercialization across precision medicine, devices, products, business models and operational improvement. She has spearheaded the development of Hackensack Meridian’s first spin-out company, called Evaluate Diagnostics, and supports innovation activity tied to the medical school and the system’s center for discovery and innovation. Ms. Powell-Elliott has scaled team-member-driven innovation through programs such as the “Bear’s Den Innovation Challenge” and networkwide challenges that have evaluated more than 400 submissions over three years, including a 2022 safety challenge engaging the system’s 36,000 team members. She helped launch “Emerge” in partnership with the State of New Jersey to accelerate early-stage technologies into U.S. healthcare delivery, beginning with an Ireland-focused cohort in 2024 and expanding in 2025 to more than 20 countries. Her portfolio also includes innovation-intensive programs targeting pediatrics, mental health, women’s health and pharmacy practice, alongside initiatives such as a genomic reference lab collaboration and ambulatory imaging joint ventures.
